These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

142 related items for PubMed ID: 21671133

  • 21. Activity of the anti-HIV agent 9-(2-phosphonyl-methoxyethyl)-2,6-diaminopurine against cytomegalovirus in vitro and in vivo.
    Neyts J, Stals F, Bruggeman C, De Clercq E.
    Eur J Clin Microbiol Infect Dis; 1993 Jun; 12(6):437-46. PubMed ID: 8395382
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Transdermal delivery of vancomycin hydrochloride: Influence of chemical and physical permeation enhancers.
    Datta D, Panchal DS, Venuganti VVK.
    Int J Pharm; 2021 Jun 01; 602():120663. PubMed ID: 33933644
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Enhanced transdermal delivery of acyclovir sodium via elastic liposomes.
    Jain SK, Gupta Y, Jain A, Rai K.
    Drug Deliv; 2008 Jun 01; 15(3):141-7. PubMed ID: 18379926
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Transdermal delivery of narcotic analgesics: pH, anatomical, and subject influences on cutaneous permeability of fentanyl and sufentanil.
    Roy SD, Flynn GL.
    Pharm Res; 1990 Aug 01; 7(8):842-7. PubMed ID: 1978306
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Systemic enhancement of papaverine transdermal gel for erectile dysfunction.
    Wen MM, El-Kamel AH, Khalil SA.
    Drug Dev Ind Pharm; 2012 Aug 01; 38(8):912-22. PubMed ID: 22080854
    [Abstract] [Full Text] [Related]

  • 34. Antitumor activity of novel purine acyclic nucleotide analogs PMEA and PMEDAP.
    Otová B, Zídek Z, Holý A, Votruba I, Sladká M, Marinov I, Lesková V.
    In Vivo; 1997 Aug 01; 11(2):163-7. PubMed ID: 9179610
    [Abstract] [Full Text] [Related]

  • 35. Omega 3 fatty acid-enriched nanoemulsion of thiocolchicoside for transdermal delivery: formulation, characterization and absorption studies.
    Kumar D, Ali J, Baboota S.
    Drug Deliv; 2016 Aug 01; 23(2):591-600. PubMed ID: 24892633
    [Abstract] [Full Text] [Related]

  • 36. Synthesis of acyclic nucleoside phosphonates.
    Holý A.
    Curr Protoc Nucleic Acid Chem; 2005 Oct 01; Chapter 14():Unit 14.2. PubMed ID: 18428938
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Trypsin as a novel potential absorption enhancer for improving the transdermal delivery of macromolecules.
    Li YZ, Quan YS, Zang L, Jin MN, Kamiyama F, Katsumi H, Tsutsumi S, Yamamoto A.
    J Pharm Pharmacol; 2009 Aug 01; 61(8):1005-12. PubMed ID: 19703343
    [Abstract] [Full Text] [Related]

  • 39. Electroporation as an efficient physical enhancer for skin drug delivery.
    Escobar-Chávez JJ, Bonilla-Martínez D, Villegas-González MA, Revilla-Vázquez AL.
    J Clin Pharmacol; 2009 Nov 01; 49(11):1262-83. PubMed ID: 19717723
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.